Advocate's Viewpoint on Hereditary Breast/Ovarian Cancer
Abstract This paper discusses the presentation I held at the symposium on genetics during the 4 th European Breast Cancer Conference held in Hamburg in March 2004. Primarily, the goals and working methods of the advocacy group specialised in Hereditary Breast/Ovarian Cancer of the Dutch Breast Cancer Patient Organisation known as BorstkankerVereniging Nederland (BVN) are explained. Furthermore, some specific individual problems that mutation carriers might encounter before and after BRCA1/2 susceptibility testing are discussed. These include: dilemmas in choosing preventive interventions, deal... Mehr ...
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2004 |
| Reihe/Periodikum: | Hereditary Cancer in Clinical Practice, Vol 2, Iss 4, Pp 199-202 (2004) |
| Verlag/Hrsg.: |
BMC
|
| Schlagwörter: | patients' viewpoint / working party on hereditary breast/ovarian cancer / dilemmas of mutation carriers / preventive surgery / BRCA1 and BRCA2 / Dutch Breast Cancer Patient Organisation / genetic discrimination / ethics of genetics / patening human genes / Neoplasms. Tumors. Oncology. Including cancer and carcinogens / RC254-282 / Genetics / QH426-470 |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-27019155 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://doi.org/10.1186/1897-4287-2-4-199 |
